LEADER 05236nam 2200625Ia 450 001 9910830325403321 005 20230721022104.0 010 $a1-282-11849-8 010 $a9786612118494 010 $a3-527-62730-8 010 $a3-527-62731-6 035 $a(CKB)1000000000774672 035 $a(EBL)481368 035 $a(OCoLC)429041122 035 $a(SSID)ssj0000256590 035 $a(PQKBManifestationID)11193121 035 $a(PQKBTitleCode)TC0000256590 035 $a(PQKBWorkID)10225859 035 $a(PQKB)10648582 035 $a(MiAaPQ)EBC481368 035 $a(EXLCZ)991000000000774672 100 $a20080130d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aTechnology transfer in biotechnology$b[electronic resource] $ea global perspective /$fedited by Prabuddha Ganguli, Rita Khanna, and Ben Prickril 210 $aWeinheim $cWiley-VCH$dc2009 215 $a1 online resource (231 p.) 300 $aDescription based upon print version of record. 311 $a3-527-31645-0 320 $aIncludes bibliographical references and index. 327 $aTechnology Transfer in Biotechnology; Contents; List of Contributors; 1 Defining the Future: Emerging Issues in Biotechnology, Intellectual Property Rights and Technology Transfer; 1.1 Introduction; 1.2 Historical Evolution of Intellectual Property Regime in Biotechnology; 1.3 Issue of Patentability of Gene Sequences, Antibodies, Early-Stage Technology/Platform and 'Insufficient Support for Claims'; 1.4 Scope of Patent Claims; 1.5 Institutional Arrangements for Technology Transfer; 1.6 Policy Issues and Challenges; Part I Technology Transfer Policy Considerations and Country/Regional 327 $a2 Technology Transfers in Europe within the Life Sciences2.1 Biology and the Development of Technology Transfers; 2.2 Involvement of Public Bodies; 2.3 Initial Contacts; 2.4 Non-Disclosure Agreements; 2.5 Preliminaries to Negotiations for a Technical Transfer Agreement; 2.6 Memorandum of Understanding or Letter of Intent; 2.7 Material Transfer Agreements; 2.8 Founder Contracts in Technology Transfers; 2.9 The Technology Transfer Agreement Contract Itself; 2.10 Ownership of the Rights; 2.11 Subject Matter of the Contract; 2.12 Domains; 2.13 Territory; 2.14 Know-How 327 $a2.15 Financial Considerations2.16 Financial Clauses; 2.17 Improvements; 2.18 Rights of First Refusal; 2.19 Circulation of Contracts; 2.20 Antistacking Clause; 2.21 Various Clauses; 2.22 Conclusions; 3 Technology Transfer at the National Institutes of Health; 3.1 Introduction; 3.2 Technology Transfer Legislation; 3.3 Impact of Bayh-Dole and Stevenson-Wydler Acts; 3.4 Growth of Technology Transfer in Government and Academic Laboratories; 3.5 NIH Efforts to Transfer Technology Globally; 3.6 International Technology Transfer by Publicly Funded Research Organizations 327 $a3.7 Patent Harmonization and Access to Medicines3.8 Final Notes on the Global Expansion of Bayh-Dole-Type Intellectual Property Regimes; 4 Current Intellectual Property Management Situation in Japan; 4.1 Introduction; 4.2 IP-Related Government Measures and Projects; 4.3 Life Sciences/Biotechnology-Related Projects; 4.4 Medical Patent/Patentability; 4.5 Policies related to University-Industry CollaborationIncorporation of National Universities; 5 Technology Transfer in China; 5.1 Introduction; 5.2 Overview; 5.2.1 Technology Import; 5.2.2 Importing Sources and Industry Dissemination 327 $a5.2.3 Biotechnology5.2.4 Technology Export; 5.2.5 Government Policy; 5.3 Legal Protection of Technology in China; 5.3.1 Patent Protection; 5.3.1.1 Patent Filing and Prosecution; 5.3.1.2 Patent Enforcement; 5.3.1.3 Patent Enforcement Data; 5.3.1.4 Strategic Considerations; 5.3.2 Trade Secret Protection; 5.3.2.1 Contractual Protection; 5.3.2.2 Protection under the Anti-Unfair Competition Law; 5.3.2.3 Criminal Sanctions; 5.3.2.4 Strategic Considerations; 5.3.3 Other Forms of Protection; 5.4 Technology Transfer in China; 5.4.1 Technology Import and Export; 5.4.1.1 Contract Law 327 $a5.4.1.2 Import and Export Regulations 330 $aHere, the world's top experts impart their knowledge and experience, many in print for the first time. By considering developing country markets, this book is the first truly global guide to technology transfer, helping companies all around the world to avoid costly mistakes in product development and to recover investments quickly. Individual sections treat trade-related aspects of intellectual property rights, technology transfer in health and healthcare as well as in agriculture and the environment. 606 $aBiotechnology$xTechnology transfer 606 $aIntellectual property 615 0$aBiotechnology$xTechnology transfer. 615 0$aIntellectual property. 676 $a660.6 701 $aGanguli$b Prabuddha$01696401 701 $aKhanna$b Rita$cPh. D.$01326259 701 $aPrickril$b Ben$01696402 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910830325403321 996 $aTechnology transfer in biotechnology$94076360 997 $aUNINA